SPARINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sparine, and what generic alternatives are available?
Sparine is a drug marketed by Wyeth Ayerst and Hikma and is included in three NDAs.
The generic ingredient in SPARINE is promazine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the promazine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SPARINE?
- What are the global sales for SPARINE?
- What is Average Wholesale Price for SPARINE?
Summary for SPARINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Patent Applications: | 416 |
| DailyMed Link: | SPARINE at DailyMed |
US Patents and Regulatory Information for SPARINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | SPARINE | promazine hydrochloride | CONCENTRATE;ORAL | 010942-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wyeth Ayerst | SPARINE | promazine hydrochloride | TABLET;ORAL | 010348-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | SPARINE | promazine hydrochloride | INJECTABLE;INJECTION | 010349-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
